Abstract
A new 1H-pyrazole-3-carboxylic acid 2, along with hydrazono-pyridazinone 3, a by-product, and its derivatives 4–7 were synthesized and the structures confirmed by infrared (IR) and 1H and 13C nuclear magnetic resonance (NMR) data. These new compounds were evaluated for their antibacterial activities against Gram-positive and Gram-negative bacteria using the tube dilution method. The minimal inhibitory concentrations (MICs) experiments revealed that most compounds exerted inhibitor effects against Klebsiella pneumonia, Escherichia coli, Bacillus subtilus, and Xanthomonas compestris test microorganisms. Moreover, the results showed that the pyrazolo[3,4-d]pyridazine compounds were the best compounds of the series, exhibiting antibacterial activity against both Gram-positive and Gram-negative bacteria.
Similar content being viewed by others
References
Akçamur Y, Penn G, Ziegler E, Sterk H, Kollenz G, Peters K et al (1986) Reactionen mit cyclischen Oxalylverbin dungen, XXIV. Zur Reaction von 4-benzoil-5-fenil-furan-2,3-dion mit phenyl hydrazonen bzw. Phenylhydrazin. Monatsh Chem 117:231. doi:10.1007/BF00809443
Akçamur Y, Şener A, İpekoğlu AM, Kollenz G (1997) Functionalization and cyclization reactions of 4-benzoyl-1,5-diphenyl-1H-pyrazole-3-carboxylic Acid. J Heterocycl Chem 34:221
Badawey E, El-Ashmawey IM (1998) Nonsteroidal antiinflammatory agents-Part 1: antiinflammatory, analgesic and antipyretic activity of some new 1-(pyrimidin-2-yl)-3-pyrazolin-5-ones and 2-(pyrimidin-2-yl)-1,2,4,5,6,7-hexahydro-3H-indazol-3-ones. Eur J Med Chem 33:349. doi:10.1016/S0223-5234(98)80002-0
Badiger VV, Bennur SC (1996) Synthesis and biological-activity of pyrazolo-pyrimidines. Indian J Heterocycl Chem 6:63
Bailey DM, Hansen PE, Hlavac AG, Baizman ER, Pearl J, DeFelice AF et al (1985) 3,4-Diphenyl-1H-pyrazole-1-propanamine antidepressants. J Med Chem 28(2):256. doi:10.1021/jm00380a020
Baraldi PG, Manfredini S, Romagnoli R, Stevanato L, Zaid AN, Manservigi R (1998) Synthesis and anti-HSV-1 activity of 6 substituted pyrazolo[3,4-d]pyridazin-7-one nucleosides. Nucleosides Nucleotides 17:2165. doi:10.1080/07328319808004307
Berber I, Cokmus C, Atalan E (2003) Characterization of Staphylococcus species by SDS-PAGE of whole cell and extracellular proteins. Microbiology 72:54. doi:10.1023/A:1022221905449
Bildirici İ, Şener A, Tozlu İ (2007) Further derivatives of 4-benzoyl-1,5-diphenyl-1H-pyrazole-3-carboxylic acid and their antibacterial activities. Med Chem Res 16:418. doi:10.1007/s00044-007-9082-z
Bruno O, Ranise A, Bondavalli F, Schenone P, D’amico M (1992) 3,5-diphenyl-1H-pyrazole derivatives X.N-substituted 1-(2-aminopropyl)-and 1-(3-amino-2-hydroxypropyl)-3,5-diphenyl-1H-pyrazoles with antiinflammatory and other activities. Il Farmaco 47:1235
Clause GW (1989) In: Understanding Microbes: A Laboratory Textbook for Microbiology. WH Freeman, New York USA, p 571
Graneto MJ, Phillips WG (1992) CA 116, 250506, US 5,093,347
Hatheway GJ, Hansch C, Kim KH, Milstein SR, Schimidt CL, Smith RN et al (1978) Antitumor 1-(X-aryl)-3,3-dialkyltriazenes. 1. Quantitative structure-activity relationships vs. L1210 leukemia in mice. J Med Chem 21:563. doi:10.1021/jm00204a012
Janus SL, Magdif AZ, Erik BP, Claus N (1999) Synthesis of triazenopyrazole derivatives as potential inhibitors of HIV-1. Monatsh Chem 130:1167
Katayama H, Oshiyama T (1997) Preparation and bioactivity of pyrazole derivatives as potential cross-linking agent. Can J Chem 75:913. doi:10.1139/v97-109
Kollenz G, Ziegler E, Ott W, Igel H (1976) Zur reaction von furandion mit H-aktiven nucleophilen. Synthesen Von Heterocyclen 1511
Kurowski M, Dunky A, Geddawi M (1986) Transsynovial distribution and protein binding of pirazolac in patients with rheumatoid arthritis. Eur J Clin Pharmacol 31:307. doi:10.1007/BF00981129
Lee DG, Kim HK, Kim SA, Park Y, Park SC, Jang SH et al (2003) Fungicidal effect of indolicidin and its interaction with phospholipid membranes. Biochem Biophys Res Commun 305:305. doi:10.1016/S0006-291X(03)00755-1
Lee DG, Shin SY, Maeng CY, Jin ZZ, Kim KL, Hahm KS (1999) Isolation and characterization of a novel antifungal peptide from Aspergillus niger. Biochem Biophys Res Commun 263:646. doi:10.1006/bbrc.1999.1428
Lee V, Hecker SJ (1999) Antibiotic resistance versus small molecules, the chemical evolution. J Med Res Rev 19:521. doi:10.1002/(SICI)1098-1128(199911)19:6<521::AID-MED4>3.0.CO;2-9
Lepage F, Hublot B (1992) European patent application EP 459 887. Chem Abstr 116:128917
Londershausen M (1996) Approaches to new parasiticides. Pestic Sci 48:269. doi:10.1002/(SICI)1096-9063(199612)48:4<269::AID-PS478>3.0.CO;2-B
Mahajan RN, Havaldar FH, Fernandes PS (1991) Syntheses and biological activity of heterocycles derived from 3-methoxy-1-phenyl-1H-pyrazole-5-carboxylate. J Indian Chem Soc 68:245
Manfredini S, Bazzanini R, Baraldi PG, Guarneri M, Simoni D, Marongiu ME et al (1992) Pyrazole-related nucleosides. Synthesis and antiviral/antitumor activity of some substituted pyrazole and pyrazolo[4,3-d]-1,2,3-triazin-4-one nucleosides. J Med Chem 35:917. doi:10.1021/jm00083a017
Manfredini S, Bazzanini R, Baraldi PG, Bonora M, Marangoni M, Simoni D et al (1996) Pyrazole-related nucleosides. 4. Synthesis and antitumor activity of some 1-tetrahydropyranyl-4-substituted pyrazoles. Anticancer Drug Des 11:193
Matyus P (1998) 3(2H)-Pyridazinones: some recent aspects of synthetic and medicinal chemistry. J Heterocycl Chem 35:1075 and references therein
Mishra PD, Wahidullah S, Kamat SY (1998) A heteroaromatic acid from marine sponge Suberites vestigium. Indian J Chem Soc Sec B 37:199
Mitscher LA, Pillai SP, Gentry EJ, Shankel DM (1999) Multiple drug resistance. J Med Res Rev 19:477. doi:10.1002/(SICI)1098-1128(199911)19:6<477::AID-MED2>3.0.CO;2-W
Ott W, Terpetschnig E, Sterk H, Kollenz G (1987) Struktur der cycloaddukte von alkylimien an furandion eine rinchtigstllung. Synthesis 176. doi:10.1055/s-1987-27879
Önal A, Akçamur Y, Altural B (1996) Synthesis of some pyrazolo-pyridazine compounds. Turk J Chem 20:159
Şener A, Bildirici İ (2004) Synthesis and some reactions of 4-benzoyl-5-phenyl-1-(2,4,6-Trichloro phenyl)-1H-pyrazole-3-carboxylic acid. Turk J Chem 28:149
Şener A, Kasımoğulları R, Şener MK, Bildirici İ, Akçamur Y (2002) Studies on the reactions of cyclic oxalyl compounds with hydrazines or hydrazones: synthesis and reactions of 4-benzoyl-1-(3-Nitrophenyl)-5-phenyl-1H-pyrazole-3-carboxylic acid. J Heterocycl Chem 39:869
Sivaprasad G, Paramasivan TP, Vaiyapuri RP, Narayanasamy M (2006) Synthesis and anti-microbial activity of pyrazolylbisindoles-Promising anti-fungal compounds. Bioorg Med Chem Lett 16:6302. doi:10.1016/j.bmcl.2006.09.019
Sridhar R, Paramasivam TP, Sundaresan E, Guruswamy S, Mondikalipudur NP, Vaiyapuri RP et al (2004) Synthesis and anti-microbial activity of 1H-pyrazole carboxylates. Bioorg Med Chem Lett 14:6035. doi:10.1016/j.bmcl.2004.09.066
Sung WS, Jung HJ, Park K, Kim HS, In-S Lee, Lee DG (2007) 2,5-Dimethyl-4-hydroxy-3(2H)-furanone (DMHF); antimicrobial compound with cell cycle arrest in nosocomial pathogens. Life Sci 80:586
Suzuki S, Inoue A (1990) Jpn Kokai Tokyo Koho JP 02 172 988 [90172988] Chem Abstr 218276t
Tewari AK, Mishra A (2001) Synthesis and anti-inflammatory activities of N 4, N 5-disubstituted-3-methyl-1H-pyrazolo[3,4-c]pyridazines. Bioorg Med Chem 9:715. doi:10.1016/S0968-0896(00)00285-6
Wiley RH, Wiley P (1964) Pyrazolones, pyrazolidones and derivatives. Wiley, New York, p 102
Ziegler E, Eder M, Belegratis C, Prewedourakis E (1967) Reaktionen von Furandion mit o-nücleophilen. Monatsh Chem 98:2249. doi:10.1007/BF00902421
Ziegler E, Kollenz G, Ott W (1973) Reaktionen von Furandion mit Schiffshen Basen. Synthesis 11:679. doi:10.1055/s-1973-22291
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bildirici, İ., Şener, A., Atalan, E. et al. Synthesis and antibacterial activity of 4-benzoyl-1-(4-carboxy-phenyl)-5-phenyl-1H-pyrazole-3-carboxylic acid and derivatives. Med Chem Res 18, 327–340 (2009). https://doi.org/10.1007/s00044-008-9130-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00044-008-9130-3